Science - USA (2022-04-29)

CAR-T Animal Studies

TestingIn Vivo Efficacy & More for Cell Therapy Research

Discover more | http://www.promab.comDiscover more | http://www.promab.comDiscover more | http://www.promab.comDiscover more | http://www.ProMab.com

Allproductsareforresearchonly

2600 Hilltop Dr, Building B, Suite C320, Richmond, CA 94806

1.866.339.0871 | [email protected]

ProMab Biotechnologiesoffers a fully comprehensive in vivo functionality service to analyze your cell

therapy product using xenograft NSG mice models. CAR-T cells can be made to expedite preclinical

research studies in xenogeneic or syngeneic mouse models. ProMab has developed patient-derived

xenograft models of different types of cancers to study and validate the efficacy of cell therapy products

against solid and hematological tumors and its microenvironment.

Histopathology

Genomic parameters

Cell phenotyping

IVIS imaging

Tox i c o l o g y

PK/PD models

Immunohistochemistry (IHC)

Cytokine panels

Tumor volume and weight

Animal Research Custom Services

CAR-Lentivirus/

Retrovirus

CAR

Vector

CAR-T

in vivoStudy

Human T cells

Mouse T cells

Custom services available.

Cancercells

CAR-Tcells

0429Product.indd 544 4/21/22 7:45 AM